{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:52:14Z","timestamp":1787169134531,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"acerus pharmaceuticals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00345-021-03819-x","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:25:06Z","timestamp":1629933906000},"page":"169-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Persistent use of medical therapy after surgery for lower urinary tract symptoms: a retrospective database analysis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9176-4334","authenticated-orcid":false,"given":"Jesse","family":"Ory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpi","family":"Nackeeran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinn","family":"Rainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemendra","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjith","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"issue":"4","key":"3819_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/JU.0000000000001298","volume":"204","author":"JK Parsons","year":"2020","unstructured":"Parsons JK et al (2020) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. J Urol 204(4):799\u2013804","journal-title":"J Urol"},{"issue":"3","key":"3819_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/JU.0000000000001558","volume":"205","author":"P Abrams","year":"2021","unstructured":"Abrams P (2021) Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2020. Letter. J Urol 205(3):938","journal-title":"J Urol"},{"issue":"12","key":"3819_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11934-020-01015-9","volume":"21","author":"RA Campbell","year":"2020","unstructured":"Campbell RA, Gill BC (2020) Medication discontinuation following transurethral prostatectomy: an unrecognized effectiveness measure? Curr Urol Rep 21(12):61","journal-title":"Curr Urol Rep"},{"key":"3819_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.urology.2019.07.039","volume":"134","author":"NC Sabharwal","year":"2019","unstructured":"Sabharwal NC et al (2019) Comparative effectiveness of transurethral prostate procedures at enabling urologic medication discontinuation: a retrospective analysis. Urology 134:192\u2013198","journal-title":"Urology"},{"issue":"41","key":"3819_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24410","volume":"24","author":"J Worthington","year":"2020","unstructured":"Worthington J et al (2020) Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT. Health Technol Assess 24(41):1\u201396","journal-title":"Health Technol Assess"},{"issue":"3","key":"3819_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/JU.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA et al (2021) Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 206(3):715\u2013724. https:\/\/doi.org\/10.1097\/JU.0000000000001778","journal-title":"J Urol."},{"issue":"6","key":"3819_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.urology.2015.07.019","volume":"86","author":"SA Strope","year":"2015","unstructured":"Strope SA et al (2015) Use of medical therapy and success of laser surgery and transurethral resection of the prostate for benign prostatic hyperplasia. Urology 86(6):1115\u20131122","journal-title":"Urology"},{"issue":"3","key":"3819_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL et al (2015) Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 175(3):401\u2013407","journal-title":"JAMA Intern Med"},{"issue":"5","key":"3819_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamainternmed.2017.0089","volume":"177","author":"B Welk","year":"2017","unstructured":"Welk B et al (2017) Association of suicidality and depression with 5alpha-reductase inhibitors. JAMA Intern Med 177(5):683\u2013691","journal-title":"JAMA Intern Med"},{"issue":"5","key":"3819_CR10","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/JU.0000000000001561","volume":"205","author":"A Lusty","year":"2021","unstructured":"Lusty A et al (2021) Cardiac failure associated with medical therapy of benign prostatic hyperplasia: a population based study. J Urol 205(5):1430\u20131437","journal-title":"J Urol"},{"issue":"2","key":"3819_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M et al (2021) Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 8(2):130\u2013140","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"3819_CR12","first-page":"36","volume":"3","author":"J Michalak","year":"2015","unstructured":"Michalak J, Tzou D, Funk J (2015) HoLEP: the gold standard for the surgical management of BPH in the 21(st) century. Am J Clin Exp Urol 3(1):36\u201342","journal-title":"Am J Clin Exp Urol"},{"issue":"3","key":"3819_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1464-410X.2011.10359.x","volume":"109","author":"PJ Gilling","year":"2012","unstructured":"Gilling PJ et al (2012) Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int 109(3):408\u2013411","journal-title":"BJU Int"},{"issue":"1","key":"3819_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/13685538.2018.1434772","volume":"22","author":"AE Calogero","year":"2019","unstructured":"Calogero AE et al (2019) Epidemiology and risk factors of lower urinary tract symptoms\/benign prostatic hyperplasia and erectile dysfunction. Aging Male 22(1):12\u201319","journal-title":"Aging Male"},{"issue":"4","key":"3819_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1159\/000052478","volume":"39","author":"OW Hakenberg","year":"2001","unstructured":"Hakenberg OW et al (2001) Is there a relationship between the amount of tissue removed at transurethral resection of the prostate and clinical improvement in benign prostatic hyperplasia. Eur Urol 39(4):412\u2013417","journal-title":"Eur Urol"},{"issue":"12","key":"3819_CR16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.11622\/smedj.2016026","volume":"57","author":"S Palaniappan","year":"2016","unstructured":"Palaniappan S et al (2016) Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate. Singap Med J 57(12):676\u2013680","journal-title":"Singap Med J"},{"issue":"4 Pt 1","key":"3819_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1097\/01.ju.0000086948.55973.00","volume":"170","author":"AH Tan","year":"2003","unstructured":"Tan AH et al (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 170(4 Pt 1):1270\u20131274","journal-title":"J Urol"},{"issue":"3","key":"3819_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/bco2.68","volume":"2","author":"M Martos","year":"2021","unstructured":"Martos M et al (2021) Impact of perioperative factors on nadir serum prostate-specific antigen levels after holmium laser enucleation of prostate. BJUI Compass 2(3):202\u2013210","journal-title":"BJUI Compass"},{"issue":"4S","key":"3819_CR19","first-page":"e572","volume":"195","author":"T Large","year":"2016","unstructured":"Large T et al (2016) MP42-09 durable symptom improvement after holmium laser enucleation of the prostate (HOLEP): analyzing outcomes at ten years in over 100 men. J Urol 195(4S):e572\u2013e572","journal-title":"J Urol"},{"key":"3819_CR20","doi-asserted-by":"publisher","unstructured":"Garden EB, Shukla D, Ravivarapu KT et al (2021) Rezum therapy for patients with large prostates (\u2265\u200980 g): initial clinical experience and postoperative outcomes. World J Urol 3:1\u20138. https:\/\/doi.org\/10.1007\/s00345-020-03548-7","DOI":"10.1007\/s00345-020-03548-7"},{"issue":"3","key":"3819_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.urology.2014.04.027","volume":"84","author":"HH Han","year":"2014","unstructured":"Han HH et al (2014) Factors associated with continuing medical therapy after transurethral resection of prostate. Urology 84(3):675\u2013680","journal-title":"Urology"},{"key":"3819_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.urology.2019.05.003","volume":"130","author":"J Campbell","year":"2019","unstructured":"Campbell J et al (2019) The utilization of benign prostatic hyperplasia and bladder-related medications after a transurethral prostatectomy. Urology 130:126\u2013131","journal-title":"Urology"},{"issue":"4","key":"3819_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.eururo.2015.04.024","volume":"68","author":"J Sonksen","year":"2015","unstructured":"Sonksen J et al (2015) Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 68(4):643\u2013652","journal-title":"Eur Urol"},{"issue":"3","key":"3819_CR24","first-page":"8802","volume":"24","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG et al (2017) Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. Study. Can J Urol 24(3):8802\u20138813","journal-title":"Can J Urol"},{"key":"3819_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2017.10.023","volume":"111","author":"KT McVary","year":"2018","unstructured":"McVary KT, Roehrborn CG (2018) Three-year outcomes of the prospective, randomized controlled Rez\u016bm System study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology 111:1\u20139","journal-title":"Urology"},{"issue":"6","key":"3819_CR26","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.juro.2016.12.045","volume":"197","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG et al (2017) Convective thermal therapy: durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol 197(6):1507\u20131516","journal-title":"J Urol"},{"issue":"13","key":"3819_CR27","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","volume":"362","author":"GL Andriole","year":"2010","unstructured":"Andriole GL et al (2010) Effect of dutasteride on the risk of prostate cancer. N Engl J Med 362(13):1192\u20131202","journal-title":"N Engl J Med"},{"issue":"8","key":"3819_CR28","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland CAC et al (2019) Anticholinergic drug exposure and the risk of dementia: a nested case\u2013control study. JAMA Intern Med 179(8):1084\u20131093","journal-title":"JAMA Intern Med"},{"issue":"3","key":"3819_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11121-014-0513-z","volume":"16","author":"EA Stuart","year":"2015","unstructured":"Stuart EA, Bradshaw CP, Leaf PJ (2015) Assessing the generalizability of randomized trial results to target populations. Prev Sci 16(3):475\u2013485","journal-title":"Prev Sci"},{"issue":"10","key":"3819_CR30","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.120.051718","volume":"143","author":"JM Franklin","year":"2021","unstructured":"Franklin JM et al (2021) Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative. Circulation 143(10):1002\u20131013","journal-title":"Circulation"},{"issue":"4","key":"3819_CR31","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","volume":"43","author":"H Quan","year":"2008","unstructured":"Quan H et al (2008) Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 43(4):1424\u20131441","journal-title":"Health Serv Res"},{"issue":"3","key":"3819_CR32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.eururo.2007.01.013","volume":"52","author":"TL Yap","year":"2007","unstructured":"Yap TL et al (2007) The relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms. Eur Urol 52(3):811\u2013818","journal-title":"Eur Urol"},{"issue":"7","key":"3819_CR33","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00345-019-02691-0","volume":"37","author":"KT Foo","year":"2019","unstructured":"Foo KT (2019) What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)? World J Urol 37(7):1293\u20131296","journal-title":"World J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-021-03819-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-021-03819-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-021-03819-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T05:06:39Z","timestamp":1643864799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-021-03819-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3819"],"URL":"https:\/\/doi.org\/10.1007\/s00345-021-03819-x","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"1 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None relevant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All data in TriNetX are deidentified, thus ethics is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All data in TriNetX are deidentified, thus informed consent is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"See above. Not applicable for animals. Re: human participants, ethics\/consent not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}